Why the study?
Coronary artery disease is a leading cause of global mortality and VWF contributes to atherothrombotic processes, prompting an evaluation of VWF levels in diabetic and non-diabetic patients.
Is there an association between Von Willebrand Factor levels, diabetes, and major adverse cardiac events in patients with coronary artery disease?
Population
65 patients (32 diabetic and 33 non-diabetic) referred to an Echocardiography and Angiography Department
Comparison
Diabetic patients vs non-diabetic patients
Design
Cohort study
Follow-up
40 days
Authors
Loading...
VWF elevation in diabetic CAD may flag added thrombotic risk; leaves open its value as prognostic marker or intervention target.
Is there an association between Von Willebrand Factor levels, diabetes, and major adverse cardiac events in patients with coronary artery disease?
Elevated Von Willebrand Factor levels are associated with diabetes and increased risk of major adverse cardiac events at 40 days.
Seyedian et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: